you'll have more options to help patients get a suitable atypical antipsychotic
February 2011
The approval of Latuda (lurasidone) means you'll have more options to help patients get a suitable atypical antipsychotic....
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote